CYCP3-1 Antibody

What is CYCP3;1 and why is it significant in plant development research?

CYCP3;1 is an epidermis-specific cyclin that plays a critical role in regulating cell proliferation in the root meristem. Research has demonstrated that CYCP3;1 is specifically expressed in the root meristem epidermis and lateral root cap (LRC), where it promotes cell division . Knockdown studies of CYCP3;1 together with its homolog CYCP3;2 (which share 86% amino acid identity) result in fewer cells in root meristems, shorter cells, and reduced meristem size . This suggests that CYCP3;1 serves as a tissue-specific regulator of cell proliferation, making it valuable for studying how cell division is controlled in specific cell types during root development.

How does CYCP3;1 interact with the cell cycle machinery?

CYCP3;1 contains a typical cyclin box domain that mediates interaction with cyclin-dependent kinases (CDKs). Biochemical experiments have revealed that:

• CYCP3;1 interacts primarily with CDKB2;1 among the five main mitotic CDKs in Arabidopsis, as demonstrated by in vitro pull-down assays

• Semi-in vivo pull-down assays confirm that CDKB2;1 pulls down CYCP3;1-GFP from transgenic plant extracts

• Bimolecular fluorescence complementation (BiFC) and co-immunoprecipitation (Co-IP) assays verify this interaction in vivo

• CYCP3;1 enhances the kinase activity of CDKB2;1, promoting phosphorylation of histone H1

Since CDKB2;1 is specifically expressed during G2 and M phases, and CYCP3;1-GFP is detected during cytokinesis, CYCP3;1 likely functions to regulate these later phases of the cell cycle in the root epidermis .

What expression patterns would I detect using CYCP3;1 antibodies?

When using CYCP3;1 antibodies for immunolocalization studies, you would expect to observe:

Three-dimensional imaging reveals that CYCP3;1-GFP signal is concentrated in the outermost cell layers of the root tip, with fluorescence density measurements confirming this epidermis-specific expression pattern . Additionally, cell cycle analysis with DAPI staining shows that CYCP3;1 is present during most cell cycle phases, including cytokinesis . In heterologous expression systems like tobacco leaves, CYCP3;1-Citrine localizes to both nucleus and cytoplasm .

How is CYCP3;1 expression regulated at the transcriptional level?

CYCP3;1 expression is subject to complex transcriptional regulation:

• Brassinosteroid (BR) signaling directly suppresses CYCP3;1 expression through BRI1-EMS-SUPPRESSOR1 (BES1), a positive downstream transcription factor in the BR pathway

• DNA pull-down assays demonstrate that BES1 strongly binds to the CYCP3;1 promoter

• ChIP-qPCR assays reveal BES1 binding is enriched primarily at positions 3, 4, and 7 in the CYCP3;1 promoter, which contain known BES1 binding motifs

• Dual-luciferase assays in Nicotiana benthamiana leaves confirm that BES1-Myc significantly inhibits CYCP3;1 expression compared to control Myc or CYCP3;1-Myc

• The transcription factor SPATULA (SPT) also negatively regulates CYCP3;1 at the transcriptional level through G-box elements in its promoter

These regulatory mechanisms link hormone signaling pathways directly to cell cycle control in specific tissues.

What are the optimal sample preparation conditions for CYCP3;1 antibody applications?

For successful detection of CYCP3;1 in plant tissues, consider these preparation protocols:

Important controls should include CYCP3D-RNAi lines (reduced signal) and gCYCP3;1-GFP lines (enhanced signal) to validate antibody specificity .

How can CYCP3;1 antibodies elucidate brassinosteroid signaling pathways?

CYCP3;1 antibodies provide valuable tools for dissecting brassinosteroid (BR) signaling mechanisms in root development:

• Quantitative analysis of CYCP3;1 protein levels following BR treatments can reveal dose-dependent responses. Research shows that treatment with 10 nmol/L epibrassinolide (eBL) reduces meristematic cell numbers to 44% in wild-type plants compared to mock treatments

• Immunoprecipitation followed by mass spectrometry can identify BR-dependent modifications of CYCP3;1 that may affect its function or stability

• ChIP experiments using both BES1 and CYCP3;1 antibodies can map how BR signaling reorganizes transcriptional complexes at the CYCP3;1 promoter

• Co-localization studies combining CYCP3;1 antibodies with markers for BR signaling components can reveal spatial relationships in the root meristem

Importantly, genetic experiments demonstrate that overexpression of CYCP3;1 partially rescues the cell division defects in eBL-treated seedlings, confirming that BR signaling inhibits root meristem cell division partially through CYCP3;1 suppression .

How can I use CYCP3;1 antibodies to investigate G2/M phase regulation in specific cell types?

To investigate G2/M phase regulation in specific cell types using CYCP3;1 antibodies:

• Combine CYCP3;1 immunolocalization with EdU labeling to correlate CYCP3;1 levels with S-phase progression

• Use flow cytometry with CYCP3;1 antibodies on protoplasts from specific cell types to quantify CYCP3;1 levels across cell cycle phases

• Perform proximity ligation assays (PLA) with antibodies against CYCP3;1 and CDKB2;1 to visualize where their interaction occurs in situ

• Analyze CYCP3;1 phosphorylation status using phospho-specific antibodies to determine how post-translational modifications affect its activity

Research shows that plants overexpressing CYCP3;1 (gCYCP3;1-GFP) have more cells expressing CYCB1;1:GUS (a G2-M phase marker) compared to wild-type, while CYCP3D-RNAi plants have fewer such cells . This confirms CYCP3;1's role in promoting cell division, specifically affecting G2-M phase progression.

What are the challenges in detecting CYCP3;1 across different experimental conditions?

Researchers should be aware of several challenges when working with CYCP3;1 antibodies:

Experimental design should account for these factors, particularly when comparing CYCP3;1 levels between different conditions or genotypes .

How can CYCP3;1 antibodies help analyze the impact of transcription factors on cell cycle regulation?

CYCP3;1 antibodies can provide valuable insights into how transcription factors regulate the cell cycle:

• For BES1-mediated regulation: ChIP-reChIP experiments using sequential immunoprecipitation with BES1 and CYCP3;1 antibodies can identify genomic regions where both proteins co-localize

• For SPT-mediated regulation: Comparing CYCP3;1 protein levels in wild-type versus SPT overexpression or knockout lines can validate the observed transcriptional suppression

• For evaluating G-box element function: Correlate CYCP3;1 protein levels with promoter occupancy in plants carrying native versus mutated G-box elements in the CYCP3;1 promoter

• For hormone response studies: Monitor CYCP3;1 protein dynamics during cytokinin treatments, which promote cell proliferation and may counteract BR-mediated suppression

Research shows that mutation of G-box elements in the CYCP3;1 promoter rescues expression when co-expressed with SPT, confirming the functional significance of these regulatory elements .

What protein-protein interactions involving CYCP3;1 can be investigated using co-immunoprecipitation?

Co-immunoprecipitation (Co-IP) with CYCP3;1 antibodies can reveal several important interaction networks:

Biochemical experiments have already confirmed the interaction between CYCP3;1 and CDKB2;1 through Co-IP, demonstrating that this approach can successfully identify CYCP3;1 binding partners . Additional interactions may provide insights into how cell cycle regulation is integrated with developmental and environmental signaling pathways.

What controls should be included when validating a CYCP3;1 antibody?

For proper validation of CYCP3;1 antibodies, include these essential controls:

• Genetic controls:

  • Wild-type plants (baseline expression)

  • CYCP3D-RNAi lines (reduced signal)

  • gCYCP3;1-GFP lines (enhanced signal)

  • cycp3;1 knockout mutants (if available; absence of signal)

• Biochemical controls:

  • Recombinant CYCP3;1 protein (positive control)

  • Recombinant CYCP3;2 protein (cross-reactivity assessment)

  • Pre-immune serum (background signal determination)

  • Blocking peptide competition (specificity verification)

• Technical controls:

  • Secondary antibody only (non-specific binding)

  • No primary antibody (background assessment)

  • Tissue-specificity controls (root vs. non-root tissues)

  • Treatment controls (e.g., BR-treated samples with expected reduced levels)

Validation should include multiple techniques (Western blot, immunoprecipitation, immunolocalization) to ensure consistent performance across applications.

What is the optimal protocol for immunolocalization of CYCP3;1 in root tissues?

For optimal immunolocalization of CYCP3;1 in root tissues:

• Sample preparation:

  • Collect 5-7 day-old seedlings grown on vertical plates

  • Fix in 4% paraformaldehyde in PBS (pH 7.4) for 1 hour under vacuum

  • Wash 3× in PBS

• Cell wall digestion:

  • Treat with 1% cellulase, 0.2% pectolyase in PBS for 15 minutes

  • Wash 3× in PBS

• Permeabilization:

  • Incubate in 0.1% Triton X-100 in PBS for 15 minutes

  • Block with 3% BSA, 0.1% Triton X-100 in PBS for 1 hour

• Antibody incubation:

  • Primary: CYCP3;1 antibody (1:200-1:500 dilution) overnight at 4°C

  • Wash 5× in PBS with 0.1% Triton X-100

  • Secondary: Fluorophore-conjugated secondary antibody (1:500) for 2 hours at room temperature

  • Wash 5× in PBS with 0.1% Triton X-100

• Counterstaining:

  • DAPI (1 μg/mL) for nuclear visualization

  • Propidium iodide (10 μg/mL) for cell wall visualization (optional)

• Mounting and imaging:

  • Mount in anti-fade medium

  • Image using confocal microscopy with appropriate channels

Based on research findings, you should expect to observe CYCP3;1 signal primarily in the root epidermis and lateral root cap, with both nuclear and cytoplasmic localization .

How can I quantitatively assess CYCP3;1 levels across different genetic backgrounds?

For quantitative comparison of CYCP3;1 levels:

• Western blot quantification:

  • Extract proteins from equal numbers of root tips (e.g., 1 mm segments)

  • Separate by SDS-PAGE and transfer to membrane

  • Probe with CYCP3;1 antibody and a loading control antibody (e.g., anti-tubulin)

  • Quantify band intensities using image analysis software

  • Normalize CYCP3;1 signal to loading control

• Immunofluorescence quantification:

  • Perform immunolocalization using identical protocols across all samples

  • Image using identical microscope settings (exposure, gain, laser power)

  • Measure fluorescence intensity in defined regions of interest (ROIs)

  • Compare at least 20-30 cells per genotype across 5-10 independent roots

• Flow cytometry:

  • Isolate protoplasts from root tips

  • Fix and permeabilize cells

  • Label with CYCP3;1 antibody and fluorescent secondary antibody

  • Analyze fluorescence intensity distribution by flow cytometry

Example data might reveal that BES1-RNAi lines show increased CYCP3;1 levels compared to wild-type, while brassinosteroid-treated seedlings show decreased levels, consistent with the transcriptional regulation by BES1 .

What approaches can detect the CYCP3;1-CDKB2;1 interaction in plant tissues?

To investigate the CYCP3;1-CDKB2;1 interaction in plant tissues:

• Co-immunoprecipitation (Co-IP):

  • Extract proteins from root tips in buffer preserving protein interactions

  • Immunoprecipitate using CYCP3;1 antibody

  • Detect CDKB2;1 in the precipitate by Western blotting

  • Include appropriate controls (IgG control, input sample)

• Proximity Ligation Assay (PLA):

  • Fix and permeabilize root tissues

  • Incubate with primary antibodies against CYCP3;1 and CDKB2;1

  • Apply PLA probes and perform ligation and amplification

  • Visualize interaction signals by fluorescence microscopy

• Bimolecular Fluorescence Complementation (BiFC):

  • Generate constructs expressing CYCP3;1 and CDKB2;1 fused to complementary fragments of a fluorescent protein

  • Transform plants or protoplasts

  • Visualize fluorescence reconstitution by microscopy

• FRET (Förster Resonance Energy Transfer):

  • Generate transgenic lines expressing CYCP3;1-CFP and CDKB2;1-YFP

  • Measure FRET efficiency in live tissues

  • Calculate interaction distances based on FRET measurements

Research has already validated the CYCP3;1-CDKB2;1 interaction using multiple methods, including in vitro pull-down, semi-in vivo pull-down, BiFC, and Co-IP assays .

How can I measure CYCP3;1-enhanced kinase activity of CDKB2;1?

To assess how CYCP3;1 enhances CDKB2;1 kinase activity:

• In vitro kinase assay:

  • Express and purify CDKB2;1-Flag with or without CYCP3;1-Myc

  • Incubate with histone H1 substrate and [γ-32P]ATP

  • Separate by SDS-PAGE and detect phosphorylation by autoradiography

  • Quantify relative phosphorylation levels

• Phospho-specific antibody detection:

  • Isolate CDKB2;1 complexes from plants with different CYCP3;1 levels

  • Perform Western blotting using antibodies against phosphorylated CDK substrates

  • Compare phosphorylation patterns and intensities

• Mass spectrometry-based phosphoproteomics:

  • Immunoprecipitate CDKB2;1 from plants with varying CYCP3;1 levels

  • Analyze phosphorylation status of co-precipitated proteins

  • Identify and quantify differentially phosphorylated substrates

Research has demonstrated that CYCP3;1-Myc enhances the phosphorylation activity of CDKB2;1-Flag on histone H1, with quantitative measurements showing increased phosphorylation levels when CYCP3;1 is present . This confirms CYCP3;1's function as a positive regulator of CDKB2;1 kinase activity.

How should I design experiments to investigate CYCP3;1 regulation by brassinosteroids?

For investigating BR regulation of CYCP3;1:

• Dose-response experiments:

  • Treat seedlings with different concentrations of brassinolide (eBL) (e.g., 1 nM, 10 nM, 100 nM)

  • Measure CYCP3;1 protein levels by Western blot

  • Count meristematic cell numbers to correlate with CYCP3;1 levels

  • Research shows 10 nM eBL reduces meristematic cell numbers to ~44% in wild-type plants

• Time-course experiments:

  • Apply eBL at a fixed concentration (e.g., 10 nM)

  • Collect samples at different time points (0, 1, 3, 6, 12, 24 hours)

  • Analyze CYCP3;1 transcript and protein levels

• Genetic interaction studies:

  • Compare BR responses in:

    • Wild-type plants

    • CYCP3;1 overexpression lines (gCYCP3;1-GFP)

    • CYCP3 knockdown lines (CYCP3D-RNAi)

    • BR signaling mutants (bes1, bri1, etc.)

    • Double mutants/transgenic combinations

• ChIP analysis of BES1 binding:

  • Perform ChIP with anti-BES1 antibodies in untreated vs. BR-treated plants

  • Quantify binding to the CYCP3;1 promoter by qPCR

  • Focus on regions containing E-box and BES1/BZR1 binding sites

The research shows that gCYCP3;1-GFP lines are less sensitive to BR treatment (10 nM eBL reduces cell numbers to 64% vs. 44% in wild-type), confirming CYCP3;1's role in mediating BR effects on root meristem .

What approaches can distinguish between CYCP3;1 and CYCP3;2 in experimental systems?

To differentiate between the highly similar CYCP3;1 and CYCP3;2 proteins:

• Antibody specificity:

  • Generate peptide antibodies targeting unique regions (14% difference)

  • Validate antibody specificity using recombinant proteins

  • Perform competition assays with specific peptides

• Transcript analysis:

  • Design primers targeting unique regions for RT-qPCR

  • Use RNA-Seq data to differentiate expression patterns

  • Employ in situ hybridization with gene-specific probes

• Protein identification:

  • Use targeted mass spectrometry to identify unique peptides

  • Analyze post-translational modifications that might differ

  • Generate epitope-tagged versions under native promoters

• Functional analysis:

  • Generate single knockouts vs. double knockdowns

  • Complement with individual genes to assess rescue

  • Create chimeric proteins to identify functional domains

Since CYCP3;1 and CYCP3;2 share 86% amino acid identity , careful experimental design is necessary to distinguish their individual contributions to root development and cell cycle regulation.

How can I investigate cell type-specific functions of CYCP3;1 in root development?

To study CYCP3;1's cell type-specific functions:

• Cell type-specific expression analysis:

  • Use fluorescence-activated cell sorting (FACS) with cell type-specific markers

  • Perform single-cell RNA-Seq on root tissues

  • Analyze CYCP3;1 protein localization using immunofluorescence with tissue landmarks

• Cell type-specific perturbation:

  • Generate transgenic lines with cell type-specific promoters driving:

    • CYCP3;1 overexpression

    • CYCP3;1 RNAi

    • CYCP3;1-CDKB2;1 fusion proteins

  • Analyze phenotypic consequences on root development

• Lineage tracing:

  • Create CYCP3;1 reporter lines with fluorescent timers

  • Track the fate of CYCP3;1-expressing cells during development

  • Correlate with changes in division patterns

• Tissue recombination:

  • Isolate epidermis from different genotypes

  • Combine with inner tissues to assess non-cell-autonomous effects

  • Analyze growth and division patterns in chimeric roots

Research has shown that CYCP3;1 is specifically expressed in root meristem epidermis and lateral root cap , suggesting that its cell type-specific expression is crucial for proper root development.

What experimental design would best characterize CYCP3;1 function during stress responses?

To investigate CYCP3;1's role in stress responses:

• Stress treatment time courses:

  • Apply various stresses (drought, salt, heat, nutrient deficiency)

  • Collect samples at multiple time points

  • Analyze CYCP3;1 transcript and protein levels

  • Correlate with meristematic cell division rates

• Comparative genotype analysis:

  • Compare stress responses in:

    • Wild-type plants

    • gCYCP3;1-GFP (overexpression)

    • CYCP3D-RNAi (knockdown)

  • Measure root growth, meristem size, and cell division rates

  • Analyze recovery dynamics after stress removal

• Hormone interaction studies:

  • Combine stresses with hormone treatments:

    • Brassinosteroids (known to suppress CYCP3;1)

    • Cytokinins (promote cell division)

    • Abscisic acid (stress hormone)

  • Analyze how hormone crosstalk affects CYCP3;1 levels

• Phosphoproteomics:

  • Compare CYCP3;1 phosphorylation status under normal vs. stress conditions

  • Identify stress-responsive kinases that might target CYCP3;1

  • Analyze how modifications affect CYCP3;1-CDKB2;1 interaction

Since BR signaling suppresses CYCP3;1 expression and stress often alters hormone homeostasis, investigating how CYCP3;1 responds to environmental challenges could reveal important insights into stress-adaptive growth regulation.

How can I design experiments to investigate how CYCP3;1 and SPT coordinately regulate cell division?

To study the coordination between CYCP3;1 and SPT in regulating cell division:

• Genetic interaction analysis:

  • Generate and analyze:

    • CYCP3;1 overexpression in spt mutant background

    • SPT overexpression in CYCP3;1 overexpression background

    • Double knockdown/knockout lines

  • Compare root growth, meristem size, and cell division patterns

• Molecular mechanism studies:

  • Perform ChIP-seq for SPT to identify genome-wide binding sites

  • Compare with known BES1 binding sites on the CYCP3;1 promoter

  • Analyze how mutations in G-box elements affect SPT binding and CYCP3;1 expression

• Protein-protein interaction analysis:

  • Investigate whether SPT and BES1 physically interact

  • Determine if they form a transcriptional repression complex

  • Analyze how their interaction is affected by hormones or environmental signals

• Cell division orientation analysis:

  • Compare division plane orientations in various genetic backgrounds

  • Correlate CYCP3;1 levels with division orientation patterns

  • Analyze cytoskeletal arrangements during prophase

Research has shown that SPT negatively regulates CYCP3;1 expression, and that mutation of G-box elements in the CYCP3;1 promoter rescues this repression . This suggests a direct transcriptional mechanism for SPT's control of cell proliferation via CYCP3;1 regulation.

What are the major research gaps in understanding CYCP3;1 function?

Despite significant progress in understanding CYCP3;1, several important research gaps remain:

• Mechanistic understanding of CYCP3;1's tissue specificity:

  • What restricts CYCP3;1 expression to the epidermis and lateral root cap?

  • How does this tissue-specific expression pattern evolve during development?

  • Are there mobile signals from CYCP3;1-expressing cells that influence neighboring tissues?

• Post-translational regulation:

  • How is CYCP3;1 protein stability regulated?

  • What phosphorylation events modify CYCP3;1 activity?

  • How do hormone signaling pathways affect CYCP3;1 at the protein level?

• Evolutionary conservation:

  • How conserved is CYCP3;1 function across plant species?

  • Do homologs in other species share similar regulation and interaction partners?

  • How has the specialized function of CYCP3;1 evolved?

• Integration with environmental responses:

  • How do abiotic stresses affect CYCP3;1 expression and function?

  • Does CYCP3;1 play a role in stress-adaptive growth responses?

  • How is CYCP3;1 regulation integrated with other hormone signaling pathways?

Addressing these gaps would advance our understanding of how cell cycle regulation is integrated with developmental programs and environmental responses in plants.

What methodological advances would enhance CYCP3;1 antibody applications in plant research?

Several methodological advances could significantly enhance CYCP3;1 antibody applications:

• Single-cell resolution techniques:

  • Combining CYCP3;1 antibodies with single-cell proteomics

  • Developing proximity labeling techniques to identify CYCP3;1 interactors in specific cell types

  • Implementing CRISPR-based tagging for endogenous CYCP3;1 visualization

• Quantitative approaches:

  • Developing absolute quantification methods for CYCP3;1 protein levels

  • Creating phospho-specific antibodies to monitor CYCP3;1 activation state

  • Implementing standardized quantification protocols across laboratories

• Live imaging capabilities:

  • Developing cell-permeable CYCP3;1 nanobodies for live-cell imaging

  • Creating fluorescent biosensors for CYCP3;1-CDKB2;1 interaction dynamics

  • Implementing optogenetic tools to manipulate CYCP3;1 function with spatiotemporal precision

• High-throughput screening:

  • Developing CYCP3;1 activity assays suitable for chemical genetics approaches

  • Creating biosensor lines for CYCP3;1 expression/activity screening

  • Implementing machine learning for automated analysis of CYCP3;1 patterns